Reference Source

0641-6254-01 · Hydromorphone Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.

What is the status for 0641-6254-01 · Hydromorphone Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.?

For 0641-6254-01, generic name is Hydromorphone Hydrochloride Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable; initial posting date is 11/01/2017, recorded from its source on 2026-11-04.

"initial_posting_date": "11/01/2017", "package_ndc": "0641-6254-01", "generic_name": "Hydromorphone Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe."

— api.fda.gov, retrieved 2026-11-04

Package NDC
0641-6254-01 verified
Generic name
Hydromorphone Hydrochloride Injection verified
Manufacturer
Hikma Pharmaceuticals USA, Inc. verified
Status
Current verified
Availability now
Unavailable verified
FDA note
Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. verified
Initial posting date
11/01/2017 verified
Last update date
10/14/2026 verified
Days in shortage
3290 our reading
Reason for shortage
Demand increase for the drug verified
Dosage form
Injection verified
Therapeutic category
Analgesia/Addiction verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "10/14/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

— all from api.fda.gov, retrieved 2026-11-04

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.